ONCY - Oncolytics Biotech Q3 2022 Earnings Preview
- Oncolytics Biotech ( NASDAQ: ONCY ) is scheduled to announce Q3 earnings results on Monday, November 7th, before market open.
- The consensus EPS Estimate is -$0.08 (+11.1% Y/Y) and the consensus Revenue Estimate is $0M
- Over the last 3 months, EPS estimates have seen 1 upward revision and 0 downward.
For further details see:
Oncolytics Biotech Q3 2022 Earnings Preview